← Leaderboards
Renee Catherine Geck
Harvard Medical School
$240,097
Attributed
$240,097
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $67.6K · FY2017–22$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$240,097 · 2
By mechanism
F32$133,576 · 1
F31$106,521 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Marcia Haigis$12,366,449
- Sarah M Chang$212,958
- Christophe O Benoist$53,813,482
- Caroline H Yi$67,136
- Carlos Federico Lopez$1,806,568
Others in their field
Other Emerging Leaders on “Drug Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,448,823
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Bruce Blough · Research Triangle Institute$19,637,160
Research focus
Drug ResistanceRegulationVariantEnzymesMalignant NeoplasmsPharmaceutical PreparationsInterestAnabolismAcetylationCancer RiskAllelesAdverse Drug ReactionAutophagocytosisBaseArginineAreaAfricanBreast Cancer Cell LineBreast Cancer TherapyBuffersCancer CellCancer Cell GrowthCancer EtiologyBreast Cancer Cell
Grant awards (5)
Functional interpretation of human G6PD variants using multiplexed analyses in S. cerevisiae$67,582
F32 · FY2022 · GM · contact PI
Functional interpretation of human G6PD variants using multiplexed analyses in S. cerevisiae$65,994
F32 · FY2021 · GM · contact PI
Regulation of arginine metabolism as a therapeutic target in breast cancer$32,641
F31 · FY2019 · CA · contact PI
Regulation of arginine metabolism as a therapeutic target in breast cancer$37,180
F31 · FY2018 · CA · contact PI
Regulation of arginine metabolism as a therapeutic target in breast cancer$36,700
F31 · FY2017 · CA · contact PI